Kenshoo to Acquire Signals Analytics to Fuel Intelligent Go-to-Market for Brands.
"Signals Analytics is a leader in innovation/trends identification across industries. Their platform provides a strong data foundation, comprehensive proprietary data ocean, built-in AI contextual engines, and a highly-flexible framework (bringing all your internal and external data together). Built with over a decade of thought leadership and execution, their next-generation advanced analytics platform will drive significant business impact on your top and bottom line!"
"Unlike competitors that offer analytics that require data collection and customization, Signals Analytics delivers a configurable data platform that has already ingested more than 13,000 different data sources. It includes curated taxonomies and more than 100 analytic models, all of which can be adapted to the needs of the business.
The company employs a rich natural language processing (NLP) core to facilitate contextual research insights that can drive critical business decisions in a more timely and accurate manner. In the pharmaceutical arena, some of the data sources that are harmonized for analysis include clinical trial data, research publications, patents, company profiles, products, and financials, among several others."
